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Abstract  
Objectives  
No published study has previously evaluated the test-retest reliability of the Short-
Form McGill Pain Questionnaire (SFMPQ), yet it is increasingly being used as a 
measure of pain. This study evaluates the test-retest reliability in patients with 
osteoarthritis. 
Methods 
A prospective, observational cohort study was undertaken using serial evaluation 
of 57 subjects at two time-points. A sample of patients awaiting primary hip or 
knee joint replacement surgery, were recruited in clinic or via post. SFMPQs were 
delivered by post 5 days apart, and a supplementary questionnaire was 
completed on the second occasion to ensure that the subjects’ pain report had 
remained stable.  
Results 
The intra-class correlation coefficient (ICC) was used as an estimate of reliability. 
For the total, sensory, affective and average pain scores high ICCs were 
demonstrated (.96, .95, .88 and .89, respectively). The current pain component 
demonstrated a lower ICC of .75. The coefficient of repeatability (CoR) was 
calculated as an estimation of the minimum metrically detectable change. The 
CoR for the total, sensory, affective, average, and current pain components were 
5.2, 4.5, 2.8, 1.4cm and 1.4, respectively.  
Discussion 
Problems of adequate completion of the SFMPQ were highlighted in this sample 
and supervision via telephone contact was required. Patients recruited in clinic, 
who had practised completing the SFMPQ, demonstrated fewer errors than those 
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recruited by post. The SFMPQ was demonstrated to be a highly reliable measure 
of pain. These results should not be generalised to a more elderly population, as 
increasing age was correlated with greater variability of the sensory component 
scores. 
 
Keywords 
Short-Form McGill Pain Questionnaire, test-retest reliability, pain measurement 
 
 4 
1. Introduction 
Pain is prevalent, costly and the most common reason for which people seek 
healthcare 1-5. The measurement of pain is complex, but considered important in 
facilitating a diagnosis and as a measure of treatment effectiveness 6. Pain 
measurement methods must adhere to key issues of reliability, validity and 
responsiveness to change 7, 8.  
It is often considered that simple pain rating scales are inappropriate to evaluate 
what is acknowledged to be a multidimensional experience 9. A multidimensional 
measure may provide a more comprehensive estimate of patients’ pain 
experiences, for which they are seeking treatment and upon which clinical 
decisions are based. The most commonly used multidimensional pain measure is 
the McGill Pain Questionnaire (MPQ) 10, 11.  
The validity of the MPQ has been generally supported by an abundance of studies 
12-23, many of which have employed factor analysis to determine independent 
groupings of items for specific patient populations 24. There is some evidence for 
the test-retest stability of the MPQ, principally from a study on 65 patients with 
chronic low back pain prior to receiving chiropractic treatment 25. However, this 
study used Pearson’s correlation coefficient as a measure of reliability, which is 
inappropriate, as it measures linear association rather than agreement 26, 27. 
Also, there is no statement regarding the stability of the patients’ pain over the 
days between completing the questionnaire. 
Two studies have reported the consistency of choice of descriptions as ranging 
from 66% to 80% agreement 19, 28, when the MPQ was completed at different 
time-points by the same patients. 
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Whilst being well validated, the MPQ takes 15 to 20 minutes to complete 10 and 
some patients have difficulty with the complexity of the vocabulary used 29. The 
Short-Form McGill Pain Questionnaire (SFMPQ) was developed to address these 
issues 30, and is increasingly being used as an outcome measure in both 
research and clinical practice but very few studies evaluate its psychometric utility 
31-36
. 
The SFMPQ was developed from the most frequently used descriptors on the 
MPQ and assesses the sensory and affective dimensions of pain. Each descriptor 
is ranked as none, mild, moderate or severe 30.  A visual analogue scale (VAS) 
for pain intensity and a verbal descriptor scale (VDS) for present pain, are 
included. The SFMPQ is frequently used as a self-report questionnaire, but there 
are no standardised patient instructions published. It is multidimensional, 
evaluating dimensions homologous with those on the MPQ, so supporting its 
content validity 30. There are no published studies evaluating its factor structure. 
It’s construction has been derived logically from the MPQ 30, which has itself 
demonstrated construct validity. Neither of these theoretical aspects of validity has 
been extensively investigated by published studies. 
Two studies have demonstrated that the concurrent criterion validity of the 
SFMPQ with the MPQ is good 30, 37. As the SFMPQ is a subset of the MPQ, a 
good correlation between the scores would be expected. It is suggested that when 
two measures designed to evaluate the same construct are tested for association, 
they will always demonstrate a statistically significant association 38.  
A search of databases from 1987 (the year of the SFMPQ’s initial publication) 
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test-retest reliability 39. The study assessed the intercorrelation of the SFMPQ 
and five other pain assessment instruments but demonstrated poor research 
design, quality of data and statistical methods. From a sample of 31 patients with 
chronic low back pain, the responses of 17 patients were not included in the final 
analysis due to insufficient data. The patients were assessed initially in a hospital 
outpatient clinic and then weekly for four or five weeks. Whilst no medication or 
physical treatment was administered, general and specific ergonomic advice was 
given, potentially affecting the stability of the patients’ symptoms over the 
evaluation period. The median coefficient of variation was calculated as the 
estimation of measurement error, but its use is not recommended for assessing 
reliability 38, 40. The study results did not support the test-retest reliability of the 
SFMPQ, with the coefficients of variation ranging from 19% to 69%.   
The SFMPQ is reported to be sensitive to clinical improvement in a variety of 
populations 30-32, 37; these studies only imply responsiveness and do not 
specifically evaluate responsiveness to change. Without evidence of the stability 
of the SFMPQ when no change in pain has occurred, any reported change in 
SFMPQ score must be interpreted with caution. The change in SFMPQ score may 
reflect the measurement error of the SFMPQ and not a change in the pain being 
measured. Thus, evidence of the SFMPQ's test-retest reliability is a precondition 
to evidence of it’s responsiveness to change. 
No studies have been published that adequately demonstrate the reliability, 
responsiveness or validity of the SFMPQ. The primary aim of this study was to 
investigate the test-retest reliability of the SFMPQ, as a first step towards 
supporting the questionnaire's use as an outcome measure in research and 
clinical practice. 
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2. Materials and Methods 
2.1 Setting and subjects  
This prospective, observational cohort study was undertaken with consecutive 
subjects who attended the outpatient orthopaedic clinic at a large teaching 
hospital in the North of England. The subjects were selected from a sample who 
were on the waiting list for primary hip or knee joint replacement surgery for 'pain-
dominant' osteoarthritis (OA), as they formed a suitable, accessible target 
population. Recruitment occurred either in clinic or via post after their clinic 
attendance. Written informed consent was obtained. Subjects were excluded from 
the study if they were unable to read or understand English, or could not indicate 
their pain description by marking the appropriate box on the SFMPQ. Ethical 
approval for the study was gained from the local research ethics committee.  
Over four months, 80 consecutive subjects were referred from the orthopaedic 
clinics for inclusion into the study; three were subsequently excluded as two had 
rheumatoid arthritis and one was partially sighted (Figure 1). Of the 77 eligible 
subjects, 71 (a 92.2% response rate) completed both SFMPQs. Subjects' 
responses were excluded from the analysis if they were unable to adequately 
complete the SFMPQ (n=5), or they reported a change in their pain on the 
supplementary questionnaire, so reflecting a pain status that was not stable (n=9). 
It is important to only include those subjects who judge that their pain is 
unchanged, as the variable being measured (pain) must be unchanged in order to 
evaluate the stability of the SFMPQ as a pain measure 41-43. Subjects who 
reported a change in their pain also reported a change in their health or physical 
function. Table 1 summarises the number of errors in completion and telephone 
clarifications required by the sample. The respondents who omitted the VAS for 
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average pain but adequately completed the sensory, affective and current pain 
sections were included in the analysis for the completed sections. There were no 
statistically significant differences (using t-tests and chi-square analysis with 
p<0.05) between the demographics of the final sample of 57 subjects included in 
the statistical analysis and the initial 71 respondents. The mean age was 64.8 
years (range 36 to 81, SD 10.4); there were 21 (36.8%) males and 36 (63.2%) 
females; 41 (71.9%) were awaiting hip arthroplasty and 16 (28.1%) knee 
arthroplasty. Further statistical exploration of the demographic characteristics 
indicated that there were no statistically significant differences between subjects 
recruited in clinic and via post, or between subjects reporting unstable and stable 
pain. However, an independent t-test demonstrated a statistically significant 
difference in the mean ages of subjects with problems completing the SFMPQ and 
those without completion problems (t=2.4, df=69, p=0.021). The mean age of 
subjects with completion problems was 68.3 years (SD 10.3), compared with 62.5 
years (SD 10.2) for subjects without completion problems. 
2.2  Pilot study 
A pilot study with 23 subjects was undertaken to optimise the recruitment method, 
SFMPQ completion, and to establish the estimations upon which the sample size 
calculations were based. The modifications made arising from the pilot were:  
 subjects recruited in clinic completed a practice SFMPQ to correct any 
initial completion errors  
 the primary researcher carried out telephone clarification of any ambiguous 
responses on returned SFMPQs 
 any reported change in the subject’s pain, indicated by the supplementary 
questions was clarified by telephone (to ensure that subjects were referring 
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to the five day period between completing the SFMPQs and not to a 
general, more long-term change). 
The predicted reliability level (ρ1) of the SFMPQ component and total scores was 
estimated as 0.9 from the pilot, the minimal acceptable reliability level (ρ0) for the 
SFMPQ was set at 0.8 (based upon the limited consensus in the literature) 44, β 
was set at 80% and α at 0.05. Using tables provided by Walter et al.’s 45 
functional approximation method, a sample of 46 subjects was identified as 
required for the main study.   
2.3 Procedure 
Subjects completed the SFMPQ (Figure 2) at two time points, ten days after their 
clinic attendance (test 1) and a further five days later (test 2). At the second time-
point, subjects also answered four supplementary questions which asked about 
any change in health, physical function, pain or medication since completion of 
the first questionnaire. Non-responders were telephoned to remind them to return 
the questionnaire. To minimise bias or errors in the data handling, an independent 
observer, blinded to the study’s aim, checked all SFMPQ scoring and a random 
20% of the data entry.  
2.4 Data analysis 
The SFMPQ was scored as recommended by Melzack 30 and therefore, was 
regarded as interval level data. It is acknowledged that there is some evidence to 
suggest that the assumption that the data from the rank descriptors is continuous 
is incorrect, and that the category items do not exhibit the assumed homogeneity 
of spacing 46.  However, the authors felt it necessary to initially establish the 
reliability of the questionnaire as devised and scored by the developers. There is 
a lack of consistency in the literature regarding choice of reliability estimates. The 
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intraclass correlation coefficient (ICC) is a preferred method of estimating 
reliability as it relates the size of the error in repeated measurements to the 
variation of interest 47, 48. A disadvantage of the ICC is that it is a ‘unit-less’ 
value, giving no indication of the actual measurement range or biases, and so it is 
difficult to interpret clinically 40, 44. The standard error of measurement (SEM) is 
the standard deviation of the measurement error and is easier to interpret 
clinically, as it is expressed in the units of measure 44. Bland and Altman 38 
advocate the use of scatter diagrams and limits of agreement. These methods 
identify biases in the scores and provide an estimate of a range of error that must 
be interpreted in the context of the variance in the individual outcome measures 
38, 49
. Bland 49 also recommends the coefficient of repeatability (CoR) for 
reliability estimation involving repeated measures. The CoR may be defined as 
the value below which the absolute difference between test-retest scores may be 
expected to lie with 95% probability 50. It reflects the measurement error and 
represents the clinical minimum detectable change in the unit of measurement. 
The current consensus is that, independently, each method has its weakness but 
by combining the methods, a more complete estimation of reliability may be 
achieved 26, 40, 44. 
Inferential statistics have not been used to explore the internal consistency of the 
item selection, as although the SFMPQ uses a summated rating scale for the item 
selection, it is not expected that all questions would score similarly. Indeed, the 
SFMPQ may theoretically be used to discriminate between diagnostic pain traits 
30
. 
Data were analysed using the Statistical Package for the Social Sciences (SPSS, 
Woking, Surrey, UK, Version 9). Plots of the difference (mean and absolute) 
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between tests 1 and 2 against the mean of tests 1 and 2 were constructed 38, 49. 
The reliability of each component score ('sensory', 'affective', 'average' and 
‘current’ pain) and the total (sensory and affective) score of the SFMPQ (Figure 3) 
were estimated using the ICC (1,1), SEM and CoR equations shown in Figure 4. 
Pearson’s correlation was carried out to test for any association between the 
variables. Two-tailed significance was set at 0.05.  
 
3. Results 
Values of the difference in SFMPQ scores over the two time-points were normally 
distributed and demonstrated homoscedasticity. Table 2 summarises the mean 
score for each component of the SFMPQ and the total score across the two time 
points. It also shows the mean and absolute differences, and 95% confidence 
intervals (CI) for the mean differences between the two scores for each 
component and the total score. The 95% CI’s for the mean difference in 
component scores at the two time points include zero, indicating no significant 
bias towards subjects scoring higher or lower at time point two. Also, the small 
mean absolute differences indicate a small magnitude of variation between the 
scores at the two time points. 
Scatter diagrams of the absolute difference against the mean, and of the mean 
difference against the mean, for each pair of scores (Figure 5) demonstrated no 
evidence of systematic bias between the magnitude of the differences and the 
magnitude of the component and total SFMPQ scores. Furthermore, no bias was 
evident for subjects scoring higher or lower on the SFMPQ at the second time-
point 38, 49.  
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The ICC values were high for the sensory, affective, average and total pain 
components (.95, .88, .89 and .96, respectively) with narrow CIs, indicating 
precise estimation of the reliability coefficient (Table 3). The 'current' pain 
dimension demonstrated a lower ICC of .75 and wider 95% CI, indicating less 
precision in this estimated coefficient.  
The SEM for the total score was 1.87, the mean total score was 18.9. The 
sensory, affective, average and current pain components all demonstrated the 
expected smaller SEMs; 1.64, 1.01, 0.52 and 0.51, respectively. The CoR values 
demonstrate a change of at least 5.18 must be evident in the total score (4.54, 
2.80, 1.44cm and 1.41 for the sensory, affective, average pain and current pain 
scores, respectively) if the change in pain is to be interpreted as a clinical change. 
The CoR reflects the precision of the SFMPQ and is considered as part of the 
overall reliability. Together, the ICC values and the CoR support the precision and 
reliability of the SFMPQ. 
Pearson's correlation coefficient demonstrated that the association between age 
and absolute difference between SFMPQ scores was statistically significant for 
the sensory component only (r= 0.31, p=0.045); indicating that the older the 
subject, the greater the difference between the sensory pain scores across the 
two time-points.  
 
4. Discussion 
4.1 Statistical Analysis 
Statistical theory provides no clear guidelines for acceptable reliability, with many 
authors ascribing different interpretations of 'acceptable' ICC values 43, 44, 48. 
The high ICCs (.88 to .96) obtained for the SFMPQ total score, and the sensory, 
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affective and average pain dimensions would suggest that the SFMPQ is a highly 
reliable, multidimensional measure of pain in this population. The SEM helps to 
place the ICC in the context of the data from which it was derived, with smaller 
SEMs indicating greater reliability 44. However, the CoR is more clinically useful 
by identifying the difference between the test-retest scores with confidence 0.95 
44, 49, 50
. In the total score, an ICC of .96 reflected a variation in the test-retest 
scores of 5.2, and the sensory component's ICC of .95 reflected a variation in the 
test-retest scores of 4.5. Hence, for a subject’s recorded change in SFMPQ to be 
detected as a clinical change it must be greater than 5.2 for the total score, or 4.5 
for the sensory component. Any change in score that is less than these values 
reflects the measurement error of the SFMPQ and is not attributable to a clinically 
meaningful change. 
4.2 Current pain component score 
A lower ICC (.75) was obtained for the current pain dimension. The pre-
determined, minimally acceptable ICC value was set at 0.8, and so the values of 
the ICC (.75) and 95% CI (.61 to .84) do not support the reliability of this 
component of the SFMPQ for use in this population of OA patients. The low ICC 
implies either a lack of stability of the current pain being evaluated, or a lack of 
stability of the measure. In this study, the current pain component evaluated the 
pain experience at a point in time, whereas, the other components of the SFMPQ 
evaluated the pain experienced over the previous 30 days. Other studies have 
demonstrated that patients’ point estimation of current pain is less reliable than 
the recall of usual or average pain 51. Therefore, this seems to suggest that it is 
the stability of the measure that is unreliable, rather than the stability of the current 
pain. 
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Alternatively, the current pain report might be expected to differ at the two time-
points, as factors such as medication and functional activities prior to completing 
the questionnaire were not controlled. Such pain variations do not reflect a 
change in the overall stability of the pain, but are a characteristic of the 
mechanical nature of the pain associated with OA. This may be considered to be 
a characteristic of the current research design and not a true reflection on the 
stability of this component of the measurement tool. Deyo et al 41 consider that 
such variability may be related to regression to the mean. Further research is 
required to more fully investigate each assertion. 
The low ICC of .75 reflects a clinical minimum detectable change of 1.4 in the 
current pain dimension. Thus, a recorded change of two points on the current pain 
score may be interpreted as a clinical change in pain, which may be clinically 
acceptable for some applications.  
4.3 Completion Problems 
It is evident from the data in Table 1 that the SFMPQ as presented to the sample 
was associated with completion problems, despite the modifications that were 
made following the pilot study, in which 57% (n=12) demonstrated completion 
problems. Many of the completion errors were minor and simple clarification of 
ambiguous responses ensured that the data could be used in all but 7% (n=5) of 
the sample. Such a high number of completion errors may reflect poor face 
validity of the SFMPQ, but if so, a low response rate would also be expected. This 
was not the case, as a 92% response rate was achieved. The SFMPQ response 
format may have resulted in the completion problems, but the same format 
(discrete tick box responses) was adopted for the supplementary questionnaire 
without similar occurrences.  
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Lack of familiarity with the descriptors offered, or the absence of words that the 
individuals would use to describe their pain, may also have affected the 
completion of the SFMPQ. A study evaluating choice of descriptors by patients 
with rheumatoid arthritis in Manchester, UK, demonstrated a disparity between 
those offered by the MPQ and those identified by the patients 52. Papageorgiou’s 
North of England population is perhaps more comparable to the study population 
than the Canadian population, upon whom the SFMPQ's and MPQ’s development 
were based, so supporting the supposition that unfamiliar descriptors on the 
SFMPQ may affect its completion. Verbal feedback obtained, whilst clarifying the 
responses, over the telephone identified that some descriptors were unfamiliar 
and, also, identified that the written instructions lacked clarity. 
The SFMPQ written instructions were brief, and the difference in completion error 
rates between the recruitment methods supports the suggestion that the 
instructions lacked clarity. Subjects recruited by post received only the SFMPQ 
with the integral instructions; 75% (n=15) made errors on completion. Whereas, 
the subjects recruited in clinic also received a verbal explanation and completed a 
practice questionnaire; 27% (n=14) made errors on completion. Although the 
verbal explanation and practice certainly assisted completion, several patients still 
had problems.  
Increasing age has been associated with problems in self-report questionnaires 
53
.  This is evidenced in this study by the statistically significant difference in the 
age of the subjects with and without completion problems, and by the correlation 
of age and greater absolute difference in the sensory component scores. Both 
findings indicate that increasing age is associated with inferior utility of the 
SFMPQ.  
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The cause of the completion problems is likely to be a combination of all the 
sources of error identified. To ensure the clinical utility of the SFMPQ as a self-
report instrument, the rate of completion errors needs to be reduced substantially, 
otherwise it seems inappropriate for this measure to be used as a self-report 
measure in large scale pragmatic trials. 
4.4 Bias Investigations 
The visual estimation and statistical analysis of bias, indicated that the method of 
recruitment did not affect the reliability of adequately completed questionnaires. 
Whilst the postal method of recruitment resulted in more SFMPQ completion 
errors, it did not affect the variability in the SFMPQ responses.  
The statistically significant association between increasing age and a greater 
difference between the sensory pain scores across the two time-points, suggests 
that age may affect the reliability of the SFMPQ. This finding has implications for 
the generalizability of the results, particularly for more elderly populations.  
4.5 Study flaws and areas for further research 
A key flaw in this study may be considered to be the lack of control regarding the 
SFMPQ completion. There was no certainty that the subject, and not a relative or 
friend, completed the SFMPQ, at both or either time-points. There was no artificial 
control of environmental factors, time of day, previous activity levels or location, all 
of which may affect pain recall and the SFMPQ completion 54. This lack of 
‘control’ however, reflects the way in which research utilising self-report 
questionnaires is undertaken. 
Having established the reliability and the clinical minimal detectable change of the 
SFMPQ, a principal area for further research would be to establish the 
responsiveness of the SFMPQ to changing pain in the same research population.  
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Further work is required to establish SFMPQ reliability in different populations, 
and the validity of the pain descriptors for a British population. 
4.6 Conclusion 
The results of this study are important, as no other published work has 
satisfactorily established the test-retest reliability of the SFMPQ.  The SFMPQ 
total score, sensory, affective and average pain components all demonstrated 
excellent reliability, when the subjects were followed-up and questionnaire 
responses clarified. The current pain component's reliability was not supported by 
the ICC and the 95% CI, but may still be clinically useful as it’s clinical minimum 
detectable change was 1.4 on a 6 point descriptor scale. Problems were identified 
in ensuring subjects could adequately complete the SFMPQ. It is suggested that 
further development of the instructions may assist the completion of the SFMPQ. 
These results apply only to the population from which the sample was drawn, 
patients with OA awaiting primary hip or knee joint replacement surgery. Any 
generalization of the results must be undertaken with caution, especially with 
regard to more elderly populations and where telephone follow-up is not available. 
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Figure 2: Short-Form McGill Pain Questionnaire 30 
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  Allocation of a rank score to each pain descriptor (0 - none; 1 - mild; 2 - moderate and 
3 - severe). 
 The sensory descriptors (the first 11) are summed to give a sensory score. Maximum 
possible score is 33. 
 The affective descriptors (the last 4) are summed to give an affective score. Maximum 
possible score is 12. 
 Total pain score by summing sensory and affective scores. Maximum possible score 
is 45. 
 The VAS average pain scale is scored continuously 0 –10, to the nearest mm, along a 
10cm line. Maximum possible score is 10.0. 
 Allocation of a rank score to the current pain intensity verbal rating scale descriptors 
(0 - no pain; 1 - mild; 2 - discomforting; 3 - distressing; 4 - horrible; and 5 - 
excruciating). Maximum possible score is 5. 
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 22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Equations used to calculate the intraclass correlation coefficient, 
the standard error measurement and the coefficient of repeatability for the 
data analyses. 
 
 
 
 
1. ICC (1,1) =       BMS - WMS            
               BMS + (k-1) WMS         
. 
2. SEM = √WMS 
 
3. CoR = 1.96√2WMS 
                    = 2.77SEM  
where:  
BMS is between subjects mean square   
WMS is within subjects mean square (taken from the one-way ANOVA, 
residual source of variation)  
k is the number of measurements per subject 
SEM is standard error of measurement 
CoR is coefficient of repeatability 
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Figure 5: Plots of the absolute difference and the mean difference of the 
mean of the two scores (test 1 and 2) against the mean of the total score of 
the SFMPQ 
The absolute difference is the difference between the scores ignoring the minus sign. The mean 
difference is the difference between the scores taking into account the minus sign, the direction of 
the difference. 
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Table 1: Summary of errors made by the sample on completion of the SFMPQ 
 
Errors in completion 
Subjects recruited 
in clinic (n=51)  
n (%) 
Subjects recruited 
by post (n=20)   
n (%) 
Total sample 
(n=71) 
n (%) 
No errors made in completion of SFMPQ 37 (72.5) 5 (25.0) 42 (59.1) 
Multiple errors / not easily clarified over the phone (subjects excluded) 1 (2.0) 4 (20.0) 5 (7.0) 
Omitted VAS for average pain (subjects included, except for this component) 3 (5.9) 2 (10.0) 5 (7.0) 
Errors in completion of the SFMPQ that could be clarified (subjects included) 10 (19.6) 9 (45.0) 19 (26.8) 
Failed to indicate in the 'none' box if the descriptor did not apply 5 (9.8) 8 (40.0) 13 (18.3) 
                 Minor error; missed out 1 or 2 descriptors 4 (7.8) 1 (5.0) 5 (7.0) 
Omitted VAS for average pain and only specified their descriptor 1 (2.0)* 0 (0.0) 1 (1.4)* 
*The rank score of the descriptors that did not apply to this subject's pain, was clarified as 'none' but his average pain VAS score could not be 
clarified. 
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Table 2: The differences between the SFMPQ scores over the two time-points 
 
 
Mean scores 
times 1 and 2 
Mean difference 
over 2 time points* 
95% CI of mean 
difference 
Absolute difference 
over 2 time points 
95% CI of 
absolute 
difference 
95% limits of 
agreement 
Sensory component 
(n=57) 
14.36 -0.04 -0.58 to 0.69 1.54 1.09 to 2.00 -4.66 to 4.59 
Affective component 
(n=57) 
4.54 0.38 -0.01 to 0.78 1.00 0.72 to 1.28 -2.48 to 3.24 
Total sensory and 
affective score (n=57) 
18.90 0.40 -0.30 to 1.11 1.95 1.46 to 2.43 -4.90 to 5.71 
Average pain (cm) 
(n=52) 
6.65 -0.12 -0.33 to 0.08 0.58 0.25 to 0.56 -1.6 to 1.35 
Current pain 
(n=57) 
2.66 -0.02 -0.22 to 0.18 0.40 0.45 to 0.71 -1.47 to 1.44 
 
CI – confidence interval 
*The negative values indicate that the scores were higher at time-point 2. 
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Table 3: Results for test-retest reliability statistical analyses 
 
 ICC  (95% CI) SEM CoR 
Sensory component (n=57) .95  (.92 to .97) 1.64 4.54 
Affective component (n=57) .88  (.81 to .93) 1.01 2.80 
Total sensory and affective score (n=57) .96  (.94 to .98) 1.87 5.18 
Average pain (n=52) .89  (.82 to .94) 0.52 1.44 
Current pain (n=57) .75  (.61 to .84) 0.51 1.41 
 
ICC - intraclass correlation coefficient  CI - confidence interval  
SEM - standard error of the measurement CoR - coefficient of repeatability   
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